YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway
Journal of Gastroenterology · 2025
DOI: 10.1007/s00535-024-02180-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Xiyu Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. Hauptthemen laut MEDLINE: F-Box-WD Repeat-Containing Protein 7, Gastrointestinal Stromal Tumors, Transcription Factors, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research, JST SPRING.
Abstract (Originalsprache)
BACKGROUND: Although imatinib (IM) and subsequent tyrosine kinase inhibitors (TKIs) significantly improve the prognosis of GIST patients by delaying metastasis and recurrence, most patients experience limited efficacy due to toxicity and secondary resistance. We evaluated Yes-associated protein (YAP), a coactivator of the Hippo pathway accounting for IM resistance and aggressive GIST phenotypes, in GISTs. The degradation of YAP is mediated by FBXW7, and FBXW7 predicts recurrence and IM efficacy for GIST patients. Here, we aimed to identify the potential of YAP as a prognostic marker for patients with GISTs, and the molecular mechanism of FBXW7-YAP pathway in GIST cells. METHODS: We measured YAP expression in 167 GIST cases using immunohistochemical staining, correlated its expression levels with clinicopathological features, and the molecular mechanism underlying the FBXW7-YAP pathway was further examined in vitro and in vivo. RESULTS: Compared to 80 (47.9%) cases in the low YAP expression group, 87 (52.1%) cases with high YAP expression associated with a poorer prognosis in terms of overall survival (P = 0.004) and recurrence-free survival (P = 0.003). YAP expression was identified as a significant independent factor affecting the 5-year overall survival (P = 0.005) and recurrence-free survival rates (P = 0.007). Moreover, YAP was directly targeted by FBXW7 to affect proliferation, invasion, and migration in GIST cells. High YAP expression correlated with FBXW7 deficiency, as shown in xenograft and metastasis mouse models. CONCLUSIONS: YAP expression serves as a predictive marker of recurrence for GIST patients with curative resection, highlighting its potential as a novel therapeutic target that warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
- Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan. maiwa217@kumamoto-u.ac.jp.
ORCID-Profile: Xiyu Wu, Masaaki Iwatsuki
Förderung
- the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research
- JST SPRING
Zitieren
APA
Wu, X., Yamashita, K., Matsumoto, C., Zhang, W., Ding, M., Harada, K., Kosumi, K., Eto, K., Ida, S., Miyamoto, Y., & Iwatsuki, M. (2025). YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02180-1
Vancouver
Wu X, Yamashita K, Matsumoto C, Zhang W, Ding M, Harada K, et al. YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway. Journal of Gastroenterology. 2025. doi:10.1007/s00535-024-02180-1
BibTeX
@article{Wu2025,
author = {Wu, Xiyu and Yamashita, Kohei and Matsumoto, Chihiro and Zhang, Weiliyun and Ding, Ming and Harada, Kazuto and Kosumi, Keisuke and Eto, Kojiro and Ida, Satoshi and Miyamoto, Yuji and Iwatsuki, Masaaki},
title = {YAP acts as an independent prognostic marker and regulates growth and metastasis of gastrointestinal stromal tumors via FBXW7-YAP pathway},
journal = {Journal of Gastroenterology},
year = {2025},
doi = {10.1007/s00535-024-02180-1}
}
EUVIMED